Search | IOVS | ARVO Journals

View

Showing 1 – 5 of 5

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Efficacy and Safety of OTX-DED Dexamethasone Intracanalicular Insert in Subjects with Dry Eye Disease: A Multicenter, Randomized, Vehicle-Controlled Phase 2 Study

Lisa Nijm; Joseph Tauber; David G. Evans; Betsy Gillick; Rabia Gurses-Ozden; Michael Goldstein

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1558 – A0283. doi:

ARVO Annual Meeting Abstract June 2022

Dry eye sign, symptom and quality of life improvements associated with administration of AR-15512

David Wirta; Michelle Senchyna; David G. Evans; Eugene B. ` McLaurin; George W Ousler; Amber E. Lewis; David Hollander

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1513 – A0238. doi:

ARVO Annual Meeting Abstract June 2017

An observational follow-up study assessing the long-term effects of bilaterally dosed topical lipoic acid choline ester eye drops for the treatment of presbyopia

Jerry M Stein; Stella M Robertson; David G Evans; Steven H Rauchman; Kenneth N Sall; Michael S Korenfeld; Travis Whitfill; Judy Gordon; Adrian Glasser; William Burns

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):330. doi:

ARVO Annual Meeting Abstract June 2017

A Phase I/II clinical study evaluating the safety and efficacy of bilaterally dosed topical lipoic acid choline ester eye drops for the treatment of presbyopia

Michael Stanton Korenfeld; David G Evans; Steven H Rauchman; Kenneth N Sall; Jerry M Stein; Stella M Robertson; Travis Whitfill; Judy Gordon; William Burns; Adrian Glasser

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):331. doi:

ARVO Annual Meeting Abstract June 2017

A Single Center Study of the Plasma Pharmacokinetics of DEXTENZA TM (dexamethasone insert) 0.4 mg in Healthy Volunteers

Eugene B McLaurin; David G Evans; Robert Noecker; Jamie Lynne Metzinger; Deepa Mulani; Jonathan H Talamo

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4106. doi:

Advertisement